To examine the variation in antibiotic management for neonates undergoing fetal myelomeningocele repair across different centers.
Analyzed antibiotic usage patterns among various Children’s Hospitals Neonatal Consortium centers
Compared practices to identify inconsistencies
Highlighted the need for evidence-based guidelines
Significant variation in antibiotic protocols observed across different centers
Lack of standardized best practices for neonatal antibiotic use post-surgery
Indicated potential gaps in clinical guidelines based on emerging evidence
Abstract
Current antibiotic use in fMMC neonates after birth varies widely between centers in North America, highlighting the need for evidence-based data to inform the development of best practice guidelines.